The cash flow from financing activities was an inflow of €0.9 million, reflecting cash inflow from the exercises of employee stock options. In the quarter, 183 thousand options (Q3 '16: 340 thousand options) were exercised.

- END –

Consolidated condensed statement of income

(€ in thousands)		Q3 '17 Unaudited		Q3 '16 Unaudited		YTD '17 Unaudited		YTD '16 Unaudited
Revenue		217,666		239,331		683,819		721,711
Cost of sales		77,149		94,690		250,323		308,507
Gross result		140,517		144,641		433,496		413,204
Research and development expenses		51,636		50,680		155,401		140,888
Amortisation of technology and databases		24,429		22,571		71,231		64,304
Marketing expenses		11,633		19,159		47,656		55,762
Selling, general and administrative expenses		58,827		51,278		160,883		142,858
Impairment charge						168,687
Total operating expenses		146,525		143,688		603,858		403,812
Operating result		-6,008		953		-170,362		9,392
Interest result		-247		-404		-740		-1,086
Other financial result		-115		513		1,741		991
Result of associates		203		97		556		558
Result before tax		-6,167		1,159		-168,805		9,855
Income tax gain/(expense)		821		-594		-1,153		7,663
Net result		-5,346		565		-169,958		17,518
Net result attributable to:
Equity holders of the parent		-5,285		595		-169,797		17,453
Non-controlling interests		-61		-30		-161		65
Net result		-5,346		565		-169,958		17,518
Basic number of shares (in thousands)		235,227		232,424		234,246		231,413
Diluted number of shares (in thousands)		237,772		235,265		237,134		234,898
EPS, € basic		-0.02		0.00		-0.72		0.08
EPS, € diluted 5		-0.02		0.00		-0.72		0.07

« Previous Page 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14  Next Page »